Diurex Water Pills
NDC Package 52389-406-22
Package Information
Diurex Water Pills is read all package directions and warnings before use.Use only as directed.Adults: One (1) pill (100mg) or two (2) pills (200 mg maximum strength) every 3 to 4 hours while symptoms persist, not to exceed 8 pills in a 24 hour period.Start taking 5 or 6 days before onset of period and continue use until desired relief is obtained or end of period.Drink 6 to 8 glasses of water daily.Recommended for use by normally healthy adults only. Marketed by Kobayashi Healthcare International, Inc., this product is identified by NDC 52389-406 and is authorized under FDA application M027.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 52389 - Kobayashi Healthcare International, Inc.
- 52389-406 - Diurex Water Pills
- 52389-406-22 - 1 BLISTER PACK in 1 CARTON / 22 TABLET, FILM COATED in 1 BLISTER PACK (52389-406-01)
- 52389-406 - Diurex Water Pills
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (52389-406). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 52389-406-22 identifies a specific commercial package of 1 blister pack in 1 carton / 22 tablet, film coated in 1 blister pack (52389-406-01) of Diurex Water Pills Xpl, labeled by Kobayashi Healthcare International, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Kobayashi Healthcare International, Inc. on August 17, 2016. The current certification is valid through May 31, 2026.
How is this Kobayashi Healthcare International, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 52389040622. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
